Tampon that tests for STIs created by British startup
Daye ’s product doubles as PCR test for chlamydia, gonorrhoea and other common infectionsA tampon is being repurposed to screen for sexually transmitted infections, with the at-home test aiming to encourage more women to seek treatment.The gynaecological health startup Daye has launched an STI diagnostic tampon, which uses a polymerase chain reaction (PCR) test to check for chlamydia, gonorrhoea, trichomonas, mycoplasma and ureaplasma, with the tampon used in place of a swab or speculum.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - November 6, 2023 Category: Science Authors: Sarah Marsh Consumer affairs correspondent Tags: Sexual health Women's health Chlamydia Gonorrhoea Society UK news Medical research Source Type: news
Visby Medical(TM) Receives FDA Clearance and CLIA Waiver at the Point of Care for PCR Sexual Health Test
The Visby Medical Sexual Health Click Test is the first instrument-free PCR test for the detection of Chlamydia, Gonorrhea and Trichomonas, with results available within 30 minutes, during the patient visit SAN JOSE, Calif., Aug. 30, 2021 -- (Healthcare... Diagnostics, FDA Visby Medical, sexually transmitted infection (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 30, 2021 Category: Pharmaceuticals Source Type: news
How Common are Co-infections with Trichomonas and Bacterial Vaginosis?
Discussion Vulvovaginitis is a common gynecological complaint for females of all ages. It is specifically the inflammation of the vulva and vagina but is used as a general term often to mean vulvar irritation, itching, and burning that can occur with or without vaginal discharge. In prepubertal females there is lack of estrogenization, and less lactobacillus species which creates a more neutral pH (normal vaginal pH is < 4.5), lack of pubic hair and fat pad which provide trauma protection, location of anus close to the vagina and tendency of poor hygiene in young children. With puberty, estrogen thickens the vaginal tis...
Source: PediatricEducation.org - May 24, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Roche receives FDA approval for cobas HPV test for use on the cobas 6800/8800 Systems to identify women at risk for cervical cancer
Basel, 21 April 2020 - Roche (SIX: RO, ROG; OTCQX:RHHBY) today announced US Food and Drug Administration (FDA) approval for the cobas ® HPV test for use on the fully automated, high-throughput cobas® 6800/8800 Systems. The cobas® HPV test identifies women at risk for cervical cancer by detecting the presence of high-risk human papillomavirus (HPV) DNA in cervical samples. Persistent high-risk HPV infections can develop into pre cancerous lesions and, if left untreated, these lesions can progress to cervical cancer.“The approval of our HPV test for the cobas 6800 and 8800 Systems enables molec...
Source: Roche Media News - April 21, 2020 Category: Pharmaceuticals Source Type: news
UCLA microbiologist Patricia J. Johnson elected to National Academy of Sciences
Patricia J. Johnson, UCLA professor of microbiology, immunology and molecular genetics, was elected to the National Academy of Sciences in recognition of her “distinguished and continuing achievements in original research.”Membership in the academy is one of the highest honors that a U.S. scientist can receive. Its members have included Albert Einstein, Thomas Edison, Orville Wright and Alexander Graham Bell. The academy today announced the election of 100 new members and 25 foreign associates.“I am very honored to be include among the ranks of such distinguished scientists,” said Johnson, who has appointments in t...
Source: UCLA Newsroom: Health Sciences - April 30, 2019 Category: Universities & Medical Training Source Type: news
Seven-Day Metronidazole Better for Trichomoniasis Tx in Women
WEDNESDAY, Oct. 17, 2018 -- A seven-day dose of metronidazole is associated with a reduced likelihood of being Trichomonas vaginalis-positive at test-of-cure compared with single-dose treatment, according to a study published online Oct. 5 in The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 17, 2018 Category: Pharmaceuticals Source Type: news
Pelvic Exam in ER Doesn't Help Predict STI for Young Females
TUESDAY, July 10, 2018 -- Pelvic examination does not increase the sensitivity or specificity for diagnosis of chlamydia, gonorrhea, or trichomonas over taking a history alone for young female patients presenting to the emergency department with... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 10, 2018 Category: Pharmaceuticals Source Type: news
Using proteomics to understand pathogens
(American Society for Biochemistry and Molecular Biology) Recent studies in the journal Molecular& Cellular Proteomics have shed light on pathogenic mechanisms of the sexually-transmitted parasite Trichomonas vaginalis and the HIV-associated opportunistic lung fungus Aspergillus. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 10, 2018 Category: International Medicine & Public Health Source Type: news
Large racial and ethnic disparity in world's most common STI
(Johns Hopkins Medicine) In a new Johns Hopkins study, researchers have added to evidence that Trichomonas vaginalis (TV), the world's most common curable sexually transmitted infection (STI), disproportionately affects the black community. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 15, 2018 Category: International Medicine & Public Health Source Type: news
The STD You've Probably Never Heard Of
The Basics Trichomoniasis (trich) is a common STI caused by a tiny parasite called Trichomonas vaginalis. An estimated 3.7 million people are infected, but because only about 30 percent show symptoms, most people don't know they have it until they get a positive test result. How You Get It The parasite gets passed during unprotected vaginal sex (can be from penis to vagina, vagina to penis, or vagina to vagina). Trich usually doesn't affect other areas, like the mouth or anus, which means this is one STD that is relatively uncommon for gay and bisexual men. What's It Like? Here's where the not-fun part comes in: When tri...
Source: Healthy Living - The Huffington Post - November 7, 2016 Category: Consumer Health News Source Type: news
Update on Laboratory Diagnosis and Epidemiology of Trichomonas vaginalis: You Can Teach an “Old” Dog “New” Trichs
Past viewpoints on Trichomonas vaginalis infection have characterized the associated clinical disease as a “nuisance” condition, with affected demographics largely being older African American females residing in urban centers. The advent of commercial molecular assays specific for T. vaginalis has offered a new outlook on trichomoniasis. Within high-prevalence sexually transmitted infection populati ons, parasite distribution is not localized to specific population centers, and T. vaginalis prevalence is elevated among both younger and older age groups. (Source: Clinical Microbiology Newsletter)
Source: Clinical Microbiology Newsletter - October 7, 2016 Category: Microbiology Authors: Erik Munson, Maureen Napierala, Kimber L. Munson Source Type: news
Trichomonas vaginalis Infection Among Homeless Adult WomenTrichomonas vaginalis Infection Among Homeless Adult Women
What is the prevalence of Trichomonas vaginalis infection among homeless women? Sexually Transmitted Infections (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 14, 2016 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news
Synedgen’s Director for Pharmaceutical Manufacturing Publishes New...
Study suggests that anti-retroviral lectins have a modest potential for preventing or treating Trichomonas infections(PRWeb September 01, 2015)Read the full story at http://www.prweb.com/releases/2015/09/prweb12934948.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 1, 2015 Category: Pharmaceuticals Source Type: news
Class II Special Controls Guideline: Nucleic Acid Amplification Assays for the Detection of Trichomonas vaginalis - Guideline for Industry and Food and Drug Administration Staff
This guideline identifies measures that FDA believes will mitigate the risks to health associated with these devices and provide a reasonable assurance of safety and effectiveness. (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - August 18, 2015 Category: Medical Equipment Source Type: news
Federal Register: Medical Devices; Immunology and Microbiology Devices; Classification of Trichomonas Vaginalis Nucleic Acid Assay
The FDA is classifying a Trichomonas vaginalis nucleic acid assay into class II (special controls). The Agency is classifying the device into class II (special controls) in order to provide a reasonable assurance of safety and effectiveness of the device. (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - August 4, 2015 Category: Medical Equipment Source Type: news